Send us a text

Dr. Michael Koren joins Kevin Geddings to discuss why atrial fibrillation (AFib) receives so much attention in advertising compared to other services hospitals provide. The cardiologist explains the financial incentives for hospitals and device manufacturers behind these marketing campaigns, contrasting them with clinical research, which has the financial and legal incentive to measure accurate data when evaluating the success rate of a particular medication or device. Dr. Koren also discusses a current research study for a new AFib monitoring patch to highlight the difference between objective medical research and profit-driven medical marketing.

Be a part of advancing science by participating in clinical research.

Have a question for Dr. Koren? Email him at [email protected]

Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn

Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!